Dr. Hua Su conducted his Ph.D. training at the Department of Biochemistry and Molecular Biology at Zhejiang University. He worked as the Postdoctoral Scholar in University of California on 2018-2022. Now, he is the Principal Investigator at Institutes of Biomedical Sciences, Fudan University, and he also is the Principal Investigator at Zhongshan-Xuhui Hospital, Fudan University. In 2022, Dr. Su established a research laboratory focus on tumor microenvironment and tumor metabolism. Dr. Su is currently the Guest Associate Editor for Frontiers in Veterinary Infectious Diseases journal, member of the American Association for Cancer Research (AACR), member of American pancreatic Association (APA) and member of American Chinese Society for Biological Sciences (SCBA). During his career, he has received many awards, including National Scholarship (2007, 2015, 2016); Roche Education Award for Excellence in Research (2017). Shanghai Leading Talent Project, 2022; National Natural Science Foundation--Outstanding Youth Project, 2022. He has published a series of papers in internationally renowned journals such as Nature, Cancer Cell, Molecular Cell, Autophagy, Nature Communications, and PNAS, revealing the relationship between macropinocytosis and classical autophagy, establishing the transcriptional regulatory mechanism of macropinocytosis, and discovering the regulatory role and mechanism of the existence of type I collagen in the occurrence and metastasis of pancreatic cancer. These findings provide new strategies for the treatment and prognosis of pancreatic cancer, and he has applied for two related US patents.